(99m)Tc-MIP-1428

N/A

Report date: 2025/11/20 16:05:05

NME

Base Information

Drug Name(99m)Tc-MIP-1428

Drug Alias Name(99m)Tc-MIP-142899mTc-MIP-1428

ClassificationRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMolecular Insight Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesMolecular Insight Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A